Monopar Therapeutics Inc. Common Stock
MNPRMonopar Therapeutics Inc. (MNPR) is a biopharmaceutical company focused on developing targeted therapies for cancer and other serious diseases. The company aims to advance innovative drug candidates through clinical development with a focus on improving patient outcomes, often emphasizing repurposing existing drugs for new therapeutic applications.
Company News
Monopar Therapeutics presented new data at AASLD showing that ALXN1840 (tiomolybdate choline) rapidly improved copper balance in Wilson disease patients through increased fecal copper excretion.
After losing some value lately, a hammer chart pattern has been formed for Monopar Therapeutics (MNPR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. Peraso posted a quarterly loss of $8.52 per share, versus analysts’ estimates for a loss of $3.76 per share. The company’s quarterly sales came in at $1.83 million versus expectations of $1.7...
Here's why penny stocks climb in value The post What Causes Penny Stocks to Climb in Price? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
